‘All Things Bugs’: Bill Gates, U.S. Military Among Investors in GMO Insect Protein for Humans – ‘Expanding into developing genetically modified insects’

0


The Bill & Melinda Gates Foundation in 2012 funded All Things Bugs, a project to “develop a novel food product made from insects to treat malnutrition in children from famine stricken areas of the world.” The company has since expanded into developing genetically modified insects, with help from the U.S. Department of Defense.

While regulators in non-U.S. countries, including Singapore, have issued approvals for specific insect-based foods, in the U.S., the regulatory landscape is murkier — there is no legal approval process or clear-cut prohibition of insects for human consumption.

As a result, insect-containing foods have reached U.S. consumers, even though one of the few existing U.S. laws that address insects in the food supply refers to them as “filth” and a form of “adulteration.”

Crickets and grasshoppers reach U.S. consumers in a variety of forms, from protein bars to protein shakes. They’re also found on restaurant menus and are promoted as pet food and animal feed ingredients.

With few U.S. regulatory barriers to contend with, investors like Bill Gates and Big Food giants such as Tyson Foods have also begun investing in “alternative protein” startups — despite mainstream media “fact-checks” claiming Gates doesn’t support the consumption of insects.

Internist Dr. Meryl Nass, founder of Door to Freedom, told The Defender lax U.S. Food and Drug Administration (FDA) regulations — under which many insect-containing foods can be classified as “Generally Regarded as Safe” (GRAS) — “means they don’t require testing” and enable the FDA to “look the other way.”

“How long will it take before we learn whether these foods are safe? It could take generations,” Nass said.

Gates, U.S. military among backers of ‘alternative protein’ startups

The Bill & Melinda Gates Foundation’s Grand Challenges Explorations program in 2012 funded All Things Bugs, a project to “develop a novel food product made from insects to treat malnutrition in children from famine stricken areas of the world,” according to Eurasia Review.

All Things Bugs has since expanded into the development of genetically modified insects. With funding from the Defense Advanced Research Projects Agency (DARPA), “we are using CRISPR/Cas9 gene editing and other methodologies to develop base technologies for creating insects as a new bioresource,” the company states.

DARPA is a research and development agency that operates under the U.S. Department of Defense.

All Things Bugs said that while insects are “a very sustainable source of protein,” it “is innovating to make them a feasible commodity for the food industry.”

Claire Robinson, managing editor of GMWatch, told The Defender, “With all GMOs [genetically modified organisms], including insects, it’s vital that they are subjected to a pre-marketing risk assessment for health and the environment.”

Robinson said, “This includes testing them for the presence of pathogens, possible allergens and substances that may be toxic to humans. Then they must be clearly labeled for the consumer.”

Gates’ investments in insect-based foods appear to be part of a broader strategy to invest in alternatives to animal-based foods for consumers.

In a February blog post, Gates said he invested in Savor, a startup producing butter made from air (carbon dioxide) and water (hydrogen). And in 2022, the Gates Foundation awarded a $4.76 million grant to Nature’s Fynd, a startup producing foods containing fungi-based protein. In 2020, Breakthrough Energy Ventures, founded by Gates, invested in Nature’s Fynd.

The U.S. government’s National Science Foundation (NSF) also is involved in the insects-as-food space, through its funding of the Center for Environmental Sustainability through Insect Farming (CEIF). Established in 2021, CEIF seeks “to develop novel methods for using insects as feed for livestock, poultry, and aquaculture.”



Source
Las Vegas News Magazine

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More